SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, has announced a strategic partnership with PT Indopasifik Teknologi Medika Indonesia, better known as Lifepack, an online prescription provider based in Indonesia. The collaboration aims to improve healthcare accessibility in Indonesia by bringing affordable and accessible healthcare to the population.
~2,000 Indonesian physicians to be on-boarded
Under the partnership, approximately 2,000 Indonesian physicians, including general practitioners and specialists, will be on-boarded and trained to provide effective patient teleconsultations through MaNaDr's platform. Once on the platform, these physicians will initiate an awareness program aimed at encouraging their Indonesian patients to consider the advantages of receiving medical care remotely via teleconsultations on MaNaDr's platform. These physicians will also gain access to the platform's AI-enabled face-scan diagnostic tools for remote diagnosis and also have the opportunity to participate in medical symposiums and knowledge-sharing initiatives with their APAC colleagues.
AI-powered Teleconsultations by MaNaDr, with Prescriptions fulfilled by Lifepack
The partnership will permit Indonesian patients, via the use of a MaNaDr mobile app, to access teleconsultations from among these physicians– as well as other preferred general practitioners or specialists on the MaNaDr platform – from the comfort of their homes. The mobile app's AI-enabled face-scan technology permits patients without measurement equipment to receive remote diagnosis. After a teleconsultation is complete, all medications prescribed by the physician will be automatically routed by the MaNaDr platform to Lifepack, which will fill the prescriptions and arrange delivery to the patient.
Lifepack Prescription Platform
"We are excited to partner with Lifepack to bring innovative healthcare solutions to Indonesia," said Co-CEO of MaNaDr, Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician. "This partnership will not only benefit Indonesian physicians and patients but also contribute to the advancement of telemedicine in the region."
Natali Ardianto, CEO of Lifepack, expressed similar sentiments, stating, "The strategic partnership between MaNaDr and Lifepack aligns with our mission to deliver impactful innovations in healthcare. We look forward to providing Indonesian residents with affordable, quality and 24x7 near-instant access to prescriptions and consultations with this partnership."
Mr. Ardianto added that Lifepack will follow-up with chronic patients to ensure their medications have been delivered in a timely fashion.
The program is set to commence in May 2024, with a full-scale rollout expected in Q4 of 2024.
MaNaDr and Lifepack said they believed the partnership represented, "a significant step towards delivering impactful healthcare innovations at reduced cost to Indonesia's 270 million citizens."
The parties also said they anticipate that as the program gains acceptance in Indonesia it would likely generate, "significant incremental revenue over the coming years."
新加坡,2024年4月23日(GLOBE NEWSWIRE)——亞太地區(“亞太地區”)的領先遠程醫療提供商Mobile-health Network(納斯達克股票代碼:MNDR)(“ManaDR” 或 “公司”)宣佈與總部位於印度尼西亞的在線處方提供商PT Indopasifik Teknologi Medika Indonesia(俗稱Lifepack)建立戰略合作伙伴關係。該合作旨在通過爲民衆提供負擔得起和可獲得的醫療保健來改善印度尼西亞醫療保健的可及性。
將有大約2,000名印度尼西亞醫生入職
根據該合作伙伴關係,大約2,000名印度尼西亞醫生,包括全科醫生和專科醫生,將接受入職和培訓,以便通過ManaDR的平台提供有效的患者遠程會診。進入該平台後,這些醫生將啓動一項宣傳計劃,旨在鼓勵他們的印度尼西亞患者考慮在ManaDR平台上通過遠程會診遠程接受醫療服務的好處。這些醫生還將獲得該平台基於人工智能的面部掃描診斷工具進行遠程診斷,還有機會與亞太地區同事一起參加醫學研討會和知識共享計劃。
由 ManadR 提供人工智能支持的遠程會診,處方由 Lifepack 提供
該合作伙伴關係將允許印度尼西亞患者通過使用ManADR移動應用程序,在家中舒適地訪問這些醫生以及ManadR平台上其他首選的全科醫生或專家的遠程會診。該移動應用程序的人工智能面部掃描技術允許沒有測量設備的患者接受遠程診斷。遠程會診完成後,ManadR平台將自動將醫生處方的所有藥物轉發給Lifepack,Lifepack將填寫處方並安排配送給患者。
Lifepack 處方平台
“我們很高興與Lifepack合作,爲印度尼西亞帶來創新的醫療保健解決方案,” ManadR聯席首席執行官、PBM高級顧問家庭醫生蕭東英博士說。“這種夥伴關係不僅將使印度尼西亞的醫生和患者受益,而且還將爲該地區遠程醫療的發展做出貢獻。”
Lifepack首席執行官納塔利·阿迪安託也表達了類似的觀點,他說:“ManadR和Lifepack之間的戰略合作伙伴關係符合我們在醫療保健領域提供有影響力的創新的使命。我們期待通過這種合作伙伴關係,爲印度尼西亞居民提供價格合理、質量上乘且近乎即時的處方藥和諮詢服務。”
Ardianto先生補充說,Lifepack將對慢性病患者進行隨訪,以確保他們的藥物及時交付。
該計劃定於2024年5月啓動,預計在2024年第四季度全面推出。
ManadR和Lifepack表示,他們認爲該合作伙伴關係是 “朝着以更低的成本爲印度尼西亞2.7億公民提供有影響力的醫療創新邁出的重要一步。”
雙方還表示,他們預計,隨着該計劃獲得印度尼西亞的認可,它可能會產生 “未來幾年可觀的增量收入”。